BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 111721
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.111721
Table 3 Effects of psychological intervention on treatment adherence, quality of life, and psychological status in ovarian cancer patients, mean ± SD/ n (%)
Assessment category
Indicator
Pre-intervention
Post-intervention
Change
Statistics
P value
        Overall effects (n = 76)Complete adherence51 (67.1)68 (89.8)+22.7%χ2 = 11.37< 0.01
QoL global score60.3 ± 7.875.9 ± 8.4+15.6t = 11.86< 0.01
Functional domain58.7 ± 7.577.6 ± 8.3+18.9t = 15.27< 0.001
SAS score53.8 ± 7.244.1 ± 6.8-9.7t = 8.36< 0.001
SDS score55.6 ± 7.445.2 ± 6.9-10.4t = 9.24< 0.001
Treatment group effects
        Combined therapy group (n = 29)Anxiety incidence17 (58.5)8 (28.0)-30.5%χ2 = 16.32< 0.001
Depression incidence18 (62.2)10 (36.4)-25.8%χ2 = 14.76< 0.001
SAS score56.8 ± 7.545.3 ± 6.9-11.5t = 10.52< 0.001
SDS score59.1 ± 7.847.4 ± 7.1-11.7t = 11.08< 0.001
QoL score58.3 ± 7.675.2 ± 8.3+16.9t = 12.34< 0.001
        Chemotherapy group (n = 20)Anxiety incidence10 (50.0)5 (25.0)-25.0%χ2 = 10.24< 0.01
Depression incidence11 (55.0)7 (35.0)-20.0%χ2 = 8.75< 0.01
SAS score54.9 ± 7.344.8 ± 6.8-10.1t = 8.73< 0.001
SDS score56.3 ± 7.546.2 ± 7.0-10.1t = 8.92< 0.001
QoL score60.8 ± 7.775.6 ± 8.3+14.8t = 10.46< 0.001
        Surgery group (n = 12)Anxiety incidence4 (33.3)2 (16.7)-16.6%χ2 = 5.620.023
Depression incidence5 (41.7)3 (25.0)-16.7%χ2 = 5.830.021
SAS score52.1 ± 7.043.6 ± 6.7-8.5t = 6.54< 0.01
SDS score53.4 ± 7.144.8 ± 6.8-8.6t = 6.82< 0.01
QoL score61.8 ± 7.975.7 ± 8.4+13.9t = 9.47< 0.001
        Targeted therapy group (n = 15)Anxiety incidence4 (26.7)2 (13.5)-13.2%χ2 = 4.830.034
Depression incidence5 (33.3)3 (21.6)-11.7%χ2 = 4.550.042
SAS score49.8 ± 6.842.3 ± 6.5-7.5t = 5.68< 0.01
SDS score51.3 ± 7.043.5 ± 6.6-7.8t = 5.93< 0.01
QoL score64.2 ± 8.177.5 ± 8.6+13.3t = 9.21< 0.001


Write to the Help Desk